Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v21,p94)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, J. R.
Right arrow Articles by Nelinson, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by White, J. R., Jr.
Right arrow Articles by Nelinson, D.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 21:14-21, 2003
© American Diabetes Association ®, Inc., 2003

Feature Article

Clarifying the Role of Insulin in Type 2 Diabetes Management

John R. White, Jr., PA-C, PharmD, Stephen N. Davis, MD, FRCP, Ramachandiran Cooppan, MD, Mayer B. Davidson, MD, Kathryn Mulcahy, RN, MSN, CDE, Gary A. Manko, MD and Donald Nelinson, PhD the Diabetes Consortium Medical Advisory Board

In Brief

The prevalence of type 2 diabetes has been increasing rapidly and with it has been resultant morbidity and mortality. Strict glycemic control reduces the progression of diabetic microvascular disease; however, most patients treated with sulfonylureas require additional insulin therapy. This article addresses common clinician concerns about prescribing insulin early in type 2 diabetes. It presents strategies for incorporating basal insulin therapy with glargine (Lantus) into a regimen that promotes compliance.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 The Diabetes EducatorHome page
S. N. Davis and S. M. Renda
Psychological Insulin Resistance: Overcoming Barriers to Starting Insulin Therapy.
The Diabetes Educator, June 1, 2006; 32(Supplement_4): 146S - 152S.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
W. J. Fu, T. E. Haynes, R. Kohli, J. Hu, W. Shi, T. E. Spencer, R. J. Carroll, C. J. Meininger, and G. Wu
Dietary L-Arginine Supplementation Reduces Fat Mass in Zucker Diabetic Fatty Rats
J. Nutr., April 1, 2005; 135(4): 714 - 721.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. Kohli, C. J. Meininger, T. E. Haynes, W. Yan, J. T. Self, and G. Wu
Dietary L-Arginine Supplementation Enhances Endothelial Nitric Oxide Synthesis in Streptozotocin-Induced Diabetic Rats
J. Nutr., March 1, 2004; 134(3): 600 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
D. Thomas-Dobersen
Case Study: A 64-Year-Old Man With a 9-Year History of Type 2 Diabetes in Whom Insulin Therapy Led to Improved Control But No Weight Gain After 6 Months
Clin. Diabetes, October 1, 2003; 21(4): 190 - 192.
[Full Text] [PDF]

Home page
 Clin. DiabetesHome page
Erratum
Clin. Diabetes, April 1, 2003; 21(2): 94 - 94.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.